Article info

PDF

Review
Glucagon like peptide-1 receptor agonists for the management of obesity and non-alcoholic fatty liver disease: a novel therapeutic option

Authors

  • Gauri Dhir Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida, USA Division of Endocrinology, Diabetes and Metabolism, Malcom Randall VA Medical Center, Gainesville, Florida, USA PubMed articlesGoogle scholar articles
  • Kenneth Cusi Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida, USA Division of Endocrinology, Diabetes and Metabolism, Malcom Randall VA Medical Center, Gainesville, Florida, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Kenneth Cusi, Department of Endocrinology, Diabetes and Metabolism Division University of Florida, Gainesville, Florida 32610, USA; kcusi{at}ufl.edu
View Full Text

Citation

Dhir G, Cusi K
Glucagon like peptide-1 receptor agonists for the management of obesity and non-alcoholic fatty liver disease: a novel therapeutic option

Publication history

  • Accepted August 12, 2017
  • First published September 15, 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.